[Methods for the analysis and treatment of cost data by micro- and gross-costing approaches].

Rev Epidemiol Sante Publique

GATE L-SE UMR 5824, centre Léon-Bérard, université de Lyon, université Claude-Bernard Lyon 1, 28, rue Laennec, 69008 Lyon, France.

Published: March 2018

This work addresses the analysis of individual cost data in the setting of interventional or observational studies using statistical analysis software once the costs per patient have been estimated. It is in fact necessary to be able to present and describe data in an appropriate manner in each of the studied health strategies and to test whether the difference in costs observed between treatment groups is due to chance or not. Furthermore, cost analysis differs from conventional statistical analysis in that cost data have a certain number of specific properties, including their use by health decision-makers. This work also addresses the difficulties that generally arise in regard to the distribution of cost; it explains why the mathematical average constitutes the only relevant measure for economists; and it outlines which analyses are required for inter-strategy cost comparisons. It also covers the issue of missing or censored data, features that are inherent to information collected regarding costs and to sensitivity analyses.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.respe.2018.02.003DOI Listing

Publication Analysis

Top Keywords

cost data
12
work addresses
8
statistical analysis
8
cost
6
data
5
[methods analysis
4
analysis treatment
4
treatment cost
4
data micro-
4
micro- gross-costing
4

Similar Publications

Enhancing Activation Energy Predictions under Data Constraints Using Graph Neural Networks.

J Chem Inf Model

January 2025

Department of Chemical Engineering, National Taiwan University, No. 1, Section 4, Roosevelt Road, Taipei 10617, Taiwan.

Accurately predicting activation energies is crucial for understanding chemical reactions and modeling complex reaction systems. However, the high computational cost of quantum chemistry methods often limits the feasibility of large-scale studies, leading to a scarcity of high-quality activation energy data. In this work, we explore and compare three innovative approaches (transfer learning, delta learning, and feature engineering) to enhance the accuracy of activation energy predictions using graph neural networks, specifically focusing on methods that incorporate low-cost, low-level computational data.

View Article and Find Full Text PDF

Evaluation of the evidence-based practices for the management of PCOS in the Latin America context: the consensus of the Latin American Association of Gynecological Endocrinology (ALEG).

Gynecol Endocrinol

December 2025

Universidad Finis Terrae, Unidad de Medicina Reprodutiva de Clínicas MEDS y Asociación Latinoamericana de Endocrinología Ginecológica (ALEG), Santiago de Chile, Chile.

Objectives: Polycystic Ovary Syndrome (PCOS) is a complex condition affecting approximately 1 in 10 women of reproductive age. However, limited data are available regarding the specific characteristics and needs of women with PCOS in Latin America. This consensus sought to evaluate the evidence-based practices for the management of PCOS for Latin American populations, consolidate regional insights, identify eventual gaps in implementation and identify key research opportunities.

View Article and Find Full Text PDF

Globally, domestic refrigerators account for over 13% of the total energy consumption in residential buildings. The brazed plate water-cooled condenser (BPWCC) is compact in size and an attractive option to reduce the energy consumption of refrigerators using domestic water tanks. This study evaluated the performance of a household refrigerator with a secondary refrigerant calorimeter and BPWCC, using an appropriate experimental setup.

View Article and Find Full Text PDF

From Vision to Reality: The EU's Pharmaceutical Reforms and the Path to Improved Access.

Pharmacoecon Open

January 2025

Department of Health Policy and Medical Technology Research Group, LSE Health, London School of Economics and Political Science, London, UK.

Disparities in access to oncology medicines in European Union (EU) member states can impact patient outcomes profoundly, with availability and timely access varying significantly across and within member states. This paper discusses the intersection of the new European Health Technology Assessment Regulation (HTAR), the provisions of the proposed pharmaceutical legislation and their potential impacts on access to oncology medicines across EU member states. The HTAR, seeking to standardise the clinical evaluation of new medicines, has the potential to streamline the evaluation process but also risks oversimplifying diverse national healthcare needs.

View Article and Find Full Text PDF

Grounded in the Present and Anticipating the Future.

Nurs Leadersh (Tor Ont)

June 2025

Director and Professor, School of Nursing Assistant Dean, Research, Faculty of Health Dalhousie University Affiliate Scientist, Nova Scotia Health Affiliate Scientist, Maritime SPOR Support Unit Halifax, NS Co-Director, Canadian Centre for Advanced Practice Nursing Research Hamilton, ON.

and along with it, the first issue of the () for the year 2025. We begin the year with significant and persistent health and healthcare challenges. Recently released data from the Canadian Institute for Health Information indicate that 5.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!